Morphosys AG Net Income

Morphosys AG (MOR) currently reports a net income of $-460M as of March 2024. That compares with $-72M in the prior-year period — down 536.3% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Morphosys AG's net income history and peer comparisons.

Morphosys AG's net income decreased from $-72M to $-460M — a 536.3% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Morphosys AG's net income of $-460M is lower than the Healthcare sector average of $16B. That is roughly 102.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Morphosys AG reported $-460M in net income as of March 2024. That compares with $-72M in the prior-year period — down 536.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-460M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Morphosys AG, and consider following MOR for alerts when major investors trade the stock.